Tradestie Institutional Equity Comparison Engine
XRAY vs HOLX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HOLX Overall Edge
HOLX Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Hologic Inc (HOLX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while XRAY counters with relative strength in Valuation. Fundamentally, XRAY trades at 6.8x Forward P/E with 4.7% operating margin (-7.5% YoY revenue) versus HOLX at 20.1x Forward P/E and 23.0% operating margin (+2.5% YoY). In options structure, XRAY sits in BREAKDOWN (<1st %ile IV; Dealer Gamma Walls on Pro) against HOLX sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
XRAY
XRAY 6.8x vs HOLX 20.1x Fwd P/E
Growth & Margin Winner
HOLX
Op Margin 4.7% vs 23.0% ยท YoY -7.5% vs +2.5%
Momentum & Technical Winner
HOLX
1Y -17.8% vs +25.5% ยท 52W Pos 2% vs 100%
Options & Structure Winner
HOLX
BREAKDOWN (<1st %ile IV) vs UNCLASSIFIED (3rd %ile IV)
XRAY
NASDAQ
DENTSPLY SIRONA Inc.
Dental Equipment & Supplies
$8.29
-2.36% 1D
Market Cap
$1.7B
1M Return
-12.74%
1Y Return
-17.76%
Forward P/E
6.8x
Unified AI Score
42.5 / 100
HOLD
Tech 34.0
Fund 53.0
Flow 60.0
Mom 60.0
HOLX
NASDAQ
Hologic Inc
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$76.01
+0.48% 1D
Market Cap
$16.9B
1M Return
+0.34%
1Y Return
+25.51%
Forward P/E
20.1x
Unified AI Score
64.2 / 100
BUY
Tech 75.0
Fund 61.0
Flow 54.0
Mom 49.2
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
XRAY -17.76%
HOLX +25.51%
Spread: +13.0 pp (XRAY Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
XRAY TTM Op. Margin: 4.7%
HOLX TTM Op. Margin: 23.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XRAY vs HOLX. Trailing 12-month operating profitability (XRAY 4.7% vs HOLX 23.0%) and valuation multiples (XRAY 6.8x vs HOLX 20.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | XRAY | HOLX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.7B | $16.9B | Larger Scale | HOLX |
| Trailing P/E Ratio Valuation | 6.6x | 31.4x | Lower Multiple | XRAY |
| Forward P/E Ratio Valuation | 6.8x | 20.1x | Lower Multiple | XRAY |
| Revenue Growth (YoY) Growth | -7.5% | +2.5% | Higher Growth | HOLX |
| Operating Margin (TTM) Profitability | 4.7% | 23.0% | Higher Margin | HOLX |
| Net Profit Margin Profitability | -3.4% | 13.2% | Higher Margin | HOLX |
| Return on Equity (ROE) Capital Efficiency | -8.6% | 10.9% | Higher ROE | HOLX |
| 52-Week Range Position Momentum | 2% ($8โ$15) | 100% ($52โ$76) | Stronger Trend | HOLX |
| Beta / 30D Volatility Risk Regime | 0.86ฮฒ ยท 54% Vol | 0.08ฮฒ ยท 3% Vol | Lower Realized Risk | HOLX |
| Unified Institutional Score Composite Signal | 42.5 / 100 (HOLD) | 64.2 / 100 (BUY) | Higher Composite | HOLX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full XRAY vs HOLX Buy Guide
XRAY
BREAKDOWN
77d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
HOLX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
3rd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither XRAY nor HOLX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.